Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Current Value
$153.031 Year Return
Current Value
$153.031 Year Return
Market Cap
$368.37B
P/E Ratio
25.29
1Y Stock Return
1.24%
1Y Revenue Growth
-8.03%
Dividend Yield
3.00%
Price to Book
5.2
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MDT | 49.74% | $109.01B | +8.12% | 3.27% |
ED | 48.77% | $33.59B | +7.16% | 3.43% |
POR | 47.02% | $4.95B | +14.95% | 4.16% |
AWK | 46.32% | $26.93B | +5.63% | 2.17% |
AVA | 45.46% | $3.07B | +11.83% | 3.68% |
AEP | 45.05% | $51.50B | +23.91% | 3.71% |
ABT | 44.09% | $203.16B | +14.93% | 1.88% |
KO | 43.90% | $269.63B | +7.86% | 3.07% |
SJW | 43.60% | $1.83B | -14.15% | 2.89% |
DTE | 43.36% | $25.20B | +17.84% | 3.35% |
AMT | 43.15% | $94.00B | +1.83% | 3.29% |
AWR | 42.67% | $3.22B | +7.55% | 2.09% |
CMS | 42.45% | $20.49B | +20.66% | 3.01% |
PPL | 42.35% | $25.19B | +29.76% | 2.97% |
LNT | 42.26% | $15.97B | +26.81% | 3.08% |
ETR | 42.18% | $32.14B | +49.00% | 3.05% |
DUK | 42.01% | $87.74B | +26.37% | 3.65% |
ATO | 41.94% | $22.79B | +31.52% | 2.19% |
PFE | 41.70% | $142.24B | -17.16% | 6.73% |
O | 41.64% | $50.04B | +6.78% | 5.49% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TGLS | 0.01% | $3.54B | +120.49% | 0.56% |
CARS | 0.01% | $1.20B | -2.01% | 0.00% |
AMSC | -0.02% | $1.25B | +257.53% | 0.00% |
MSDL | -0.02% | $1.83B | +0.66% | 7.26% |
ATOM | -0.02% | $160.01M | -20.00% | 0.00% |
ERJ | 0.03% | $6.92B | +134.10% | 0.00% |
OII | -0.04% | $2.78B | +32.07% | 0.00% |
PBYI | 0.04% | $134.50M | -28.83% | 0.00% |
ANGI | 0.04% | $987.36M | -5.71% | 0.00% |
VVV | 0.04% | $4.98B | +11.54% | 0.00% |
CHRD | 0.06% | $7.82B | -19.23% | 5.23% |
GIC | 0.09% | $1.04B | -25.63% | 3.67% |
FTNT | 0.10% | $69.59B | +72.67% | 0.00% |
EW | -0.11% | $41.40B | +4.84% | 0.00% |
CSTM | 0.12% | $1.70B | -32.91% | 0.00% |
RRC | -0.14% | $8.29B | +4.16% | 0.92% |
SANM | -0.15% | $4.20B | +56.10% | 0.00% |
TOST | 0.15% | $24.14B | +207.53% | 0.00% |
CCL | 0.15% | $31.85B | +76.97% | 0.00% |
VET | 0.16% | $1.57B | -21.53% | 3.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CAMT | -38.93% | $3.40B | +16.39% | 0.00% |
VRT | -37.81% | $52.90B | +230.61% | 0.07% |
NVDA | -35.63% | $3.61T | +194.35% | 0.07% |
LRCX | -31.20% | $90.29B | -0.80% | 11.86% |
ASML | -30.85% | $260.51B | -3.25% | 1.03% |
SNPS | -30.76% | $82.03B | -1.18% | 0.00% |
ONTO | -30.24% | $8.04B | +20.50% | 0.00% |
AMAT | -30.21% | $139.58B | +13.44% | 0.85% |
NVMI | -29.85% | $5.16B | +44.02% | 0.00% |
FORM | -29.42% | $2.93B | -1.71% | 0.00% |
KLAC | -29.12% | $82.35B | +11.80% | 0.98% |
AVGO | -28.09% | $772.28B | +68.52% | 9.87% |
TSM | -27.43% | $983.61B | +92.73% | 1.17% |
VECO | -27.23% | $1.48B | -9.94% | 0.00% |
CDNS | -26.68% | $82.18B | +10.81% | 0.00% |
ETN | -26.61% | $143.73B | +60.21% | 1.02% |
APH | -26.09% | $85.57B | +58.31% | 1.00% |
VST | -24.85% | $52.69B | +349.00% | 0.56% |
ANET | -24.72% | $118.95B | +75.41% | 0.00% |
CLS | -24.49% | $10.10B | +223.71% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LVHD | 57.04% | $560.70M | 0.27% |
HDV | 55.37% | $11.19B | 0.08% |
FDL | 53.58% | $4.50B | 0.45% |
SPHD | 53.13% | $3.46B | 0.3% |
SPLV | 49.84% | $8.93B | 0.25% |
SDY | 48.77% | $21.19B | 0.35% |
IHE | 47.10% | $596.23M | 0.39% |
NOBL | 46.74% | $12.44B | 0.35% |
SPYD | 46.60% | $6.92B | 0.07% |
LGLV | 45.94% | $811.95M | 0.12% |
FVD | 45.73% | $9.70B | 0.6% |
KNG | 45.54% | $3.53B | 0.75% |
SCHD | 44.71% | $65.70B | 0.06% |
PEY | 44.60% | $1.24B | 0.53% |
XLV | 44.58% | $38.41B | 0.09% |
DHS | 44.52% | $1.20B | 0.38% |
RSPH | 44.51% | $885.96M | 0.4% |
CDC | 44.50% | $821.08M | 0.38% |
DVY | 44.07% | $20.66B | 0.38% |
IYK | 43.56% | $1.30B | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IMOM | 0.04% | $80.57M | 0.39% |
EWJV | -0.08% | $258.12M | 0.15% |
IZRL | 0.11% | $102.75M | 0.49% |
DRIV | 0.12% | $417.14M | 0.68% |
VIXY | -0.15% | $195.31M | 0.85% |
BBJP | 0.16% | $11.60B | 0.19% |
EWJ | -0.21% | $13.80B | 0.5% |
CNBS | 0.22% | $21.10M | 0.77% |
FLQL | -0.24% | $1.46B | 0.29% |
IBTE | 0.26% | $1.70B | 0.07% |
JPXN | -0.31% | $181.98M | 0.48% |
USSG | 0.31% | $959.04M | 0.09% |
SFLR | 0.32% | $552.90M | 0.89% |
XMMO | 0.33% | $2.99B | 0.34% |
XLSR | -0.36% | $643.89M | 0.7% |
CORN | -0.41% | $61.12M | 0.2% |
FTLS | 0.46% | $1.62B | 1.46% |
PBP | 0.49% | $92.98M | 0.2% |
SUSL | 0.51% | $997.53M | 0.1% |
DSI | 0.52% | $4.87B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SMH | -32.14% | $23.66B | 0.35% |
PSI | -29.30% | $711.93M | 0.56% |
QQA | -29.12% | $135.01M | 0% |
SOXQ | -28.80% | $490.35M | 0.19% |
FFOG | -28.00% | $118.40M | 0.55% |
SOXX | -27.47% | $13.20B | 0.35% |
IGPT | -26.75% | $407.54M | 0.58% |
IYW | -26.20% | $19.23B | 0.39% |
IXN | -25.49% | $5.14B | 0.41% |
FTXL | -25.36% | $1.31B | 0.6% |
AMDY | -24.64% | $144.24M | 0.99% |
FTEC | -24.31% | $12.59B | 0.084% |
WINN | -24.31% | $620.54M | 0.57% |
FEPI | -24.29% | $406.41M | 0.65% |
QGRW | -24.21% | $584.66M | 0.28% |
FBCG | -23.98% | $2.55B | 0.59% |
JGRO | -23.98% | $3.98B | 0.44% |
IGM | -23.87% | $5.60B | 0.41% |
XLK | -23.80% | $71.43B | 0.09% |
VGT | -23.58% | $80.62B | 0.1% |
MarketWatch
Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains
SeekingAlpha
Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.
MarketWatch
Dr. Oz Goes From TV to the Most Important Job in Healthcare. Here’s What CMS Actually Does.
Finnhub
RARITAN - Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society...
SeekingAlpha
We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.
SeekingAlpha
Investment activity in October focused on Business Development Companies. Check out my portfolio, my main picks, and my target for 2024.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.